Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
Official title: Defining Orbitofrontal Circuit Function in Health and Depression
Run by University of California, San Francisco · NCT07896343 · Data updated 2026-11-12
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | October 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07896343 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older with depression who have sEEG implants including OFC and are part of the PRESIDIO trial or undergoing related inpatient monitoring, plus suitable non-depressed controls with inpatient sEEG for other indications.
✕Probably not a fit
Patients without orbitofrontal cortex involvement in the implanted monitoring or without depressive symptoms may have limited direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will examine neural signals from depth electrodes implanted in the orbitofrontal cortex while participants perform an approach-avoidance decision task. The study compares individuals with major depressive disorder to non-depressed controls to see if medial OFC activity favors approach and lateral OFC activity favors avoidance, and whether depression shifts these signals. It leverages inpatient sEEG monitoring to directly measure brain activity during decision making related to potential rewards and losses. The findings aim to clarify brain mechanisms that contribute to reduced motivation in depression.
Why it matters
Potential benefit: Understanding OFC signaling could inform targeted approaches to improve motivation and decision making in depression.
How similar studies have gone: Prior work shows OFC involvement in reward and risk decisions, but this precise approach in depression with sEEG is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All participants: * 18 years of age or older * Implanted with stereo-EEG (sEEG) depth electrodes, including at least one electrode in the orbitofrontal cortex (OFC) * Able to read, write, and provide informed consent Depressed cohort: * Enrolled in the PRESIDIO trial (NCT04004169) of deep brain stimulation for treatment-resistant depression and undergoing inpatient sEEG monitoring as part of that trial * Meets DSM-5 criteria for major depressive disorder (single episode of at least 2 years' duration, or recurrent), without psychotic features, confirmed by structured clinical interview (e.g., MINI) Control (non-depressed) cohort: * Undergoing inpatient sEEG monitoring for a clinical indication other than depression (e.g., seizure localization in refractory epilepsy) * No current diagnosis of major depressive disorder, confirmed by clinical psychiatric evaluation (e.g., MINI and symptom scales) Exclusion Criteria: All participants: * Current or past DSM-5 diagnosis of a psychotic disorder or major depressive disorder with psychotic features * Current or past DSM-5 diagnosis of bipolar or related disorder * Current obsessive-compulsive disorder * Intellectual disability * Autism spectrum disorder * Borderline, antisocial, histrionic, or narcissistic personality disorder * Impaired decision-making capacity or cognitive deficits that preclude informed consent or task completion * Employee of the investigator or study site with direct involvement in the study, or family member of the investigator Control (non-depressed) cohort only: \* Epileptiform abnormalities involving the OFC, OFC dysplasia, or prior OFC resection, as determined by clinical evaluation and imaging
Where it's running
-
UCSF
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Andrew Krystal, MD — University of California, San Francisco
- Study coordinator: Clara K Starkweather, MD, PhD
- Email: clara.starkweather@ucsf.edu
- Phone: 706-330-0885
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Medically tailored groceries to help depression in people with food insecurity
This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.
-
Health and Work Ability After Inpatient Treatment for Stress-Related Disorders: Follow-Up of the HARMODI Cohort
This study follows people who had inpatient treatment for stress-related disorders to see how their health and ability to work change over the next three years and what factors help them return to work.
-
ADAPT: a new parenting program to help depressed parents improve their kids’ behavior
A new parenting program called ADAPT tests whether tailored support for parents with depression helps reduce their child’s emotional and behavioral problems better than the standard Incredible Years Parenting Program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.